LM N°1/ 2024. GOOD PRACTICES FOR THE PREPARATION OF AUTOLOGOUS PLATELET-RICH PLASMA (PRP-A) FROM THE RECIPIENT'S OWN BLOOD. Daphné V. DIERMAN, PhD Pharmacist, Antoine TURZI, CEO RegenLab.
New cell therapies characterized as autologous (organic substance from which the donor and
the recipient is the same individual) are found on the market, their preparations are dependent on
the use of medical devices certified by an accredited organization, enabling them to minimize
risks of contamination (infection), standardize the steps in a closed circuit and demonstrate the efficiency of the process.
therapeutic.
We will discuss the preparation of biological products derived from human blood for therapeutic purposes.
and specifically the preparation of autologous platelet-rich plasma (PRP-A).
LM N°1/ 2024. MOTIVATION TO STUDY THE EFFECT OF PLATELET-RICH PLASMA (PRP) ON POST-CHEMOTHERAPY ALOPECIA (APC) AND POST-ENDOCRINE THERAPY ALOPECIA (APE). Leore LAVIN MS, Alex PAN MD, Anthony ROSSI MD, Antoine TURZI.
MOTIVATION TO STUDY THE EFFECT OF PRP ON CHEMOTHERAPY-INDUCED ALOPECIA (CIA) AND ENDOCRINE THERAPY-INDUCED ALOPECIA (EIA). Leore LAVIN MS, Alex PAN MD, Anthony ROSSI MD, Antoine TURZI, CEO Regen Lab. THE FINDING: ADDITIONAL TREATMENT OPTIONS ARE NEEDED FOR PATIENTS SUFFERING FROM ALOPECIA RESULTING FROM ENDOCRINE THERAPY.
LM N°1/ 2024. PLATELET-RICH PLASMA AS A SAFE AND EFFECTIVE AUTOLOGOUS TREATMENT FOR CHRONIC WOUND HEALING. Solange VISCHER, Antoine TURZI.
PLATE-RICH PLASMA AS A SAFE AND EFFECTIVE AUTOLOGOUS TREATMENT FOR THE CICATRIZATION OF CHRONIC WOUND Solange VISCHER, Senior Scientific Advisor, Regen Lab SA. Antoine TURZI CEO, Regen Lab SA. Abstract Platelet-rich plasma (PRP) is an autologous biologic drug prepared from a patient's own blood and used as a treatment for the treatment of chronic [...].
LM N°1/ 2024. PLATELET-RICH PLASMA AS A TREATMENT FOR OSTEOARTHRITIS OF THE KNEE. Solange Vischer, Antoine Turzi.
ANOTHER LOOK PLASMA RICHED IN PLATES AS A TREATMENT FOR ARTHROSE OF THE KNEE Solange VISCHER, Antoine TURZI. 1 Senior Scientific Advisor, Regen Lab SA, Switzerland; 2. CEO, Regen Lab SA, Switzerland Abstract Platelet-rich plasma (PRP) is an autologous biologic drug prepared from the patient's own blood and used as a treatment for arthrosis of the [...].
LM N°1/ 2024. EVALUATION OF PLATELET-RICH PLASMA (PRP) AS AN ALTERNATIVE TO FETAL CALF SERUM (FBS) IN THE EXPANSION OF HUMAN MYOBLASTS: AN IN VITRO PROTOCOL. Axel TOLLANCE, Diego MICHEL ,Alexandre PROLA , Axelle BOUCHE , Antoine TURZI, Didier HANNOUCHE, Thomas LAUMONIER, and Sarah BERNDT.
LM N°1/ 2024. PLATELET-RICH PLASMA (PRP) AS AN ALTERNATIVE TO FETAL CALF SERUM (FBS) IN THE EXPANSION OF HUMAN MYOBLASTS: AN IN VITRO PROTOCOL. Axel TOLLANCE, Diego MICHEL, Alexandre PROLA, Axelle BOUCHE, Antoine TURZI, Didier HANNOUCHE, Thomas LAUMONIER and Sarah BERNDT
Muscular diseases, whether congenital, acquired or degenerative, are a major cause of death.
major challenge for public health, affecting patients' quality of life and often leading to
significant morbidity. Muscle regeneration is a complex process involving the
participation of various cell populations, notably muscle stem cells (MSCs),
which play a central role in restoring muscle integrity and function after
lesions [1, 2]. However, in pathological conditions such as muscular dystrophy of
Duchenne muscular dystrophy (DMD), muscle regeneration capacities are compromised, highlighting
the need to develop new therapeutic approaches to treat these diseases
debilitating muscular problems.
LM N°1/ 2024. ANGIOGENESIS, A KEY STEP IN TISSUE REGENERATION, IS MODULATED BY PLATELETS. Sarah BERNDT PhD, Gilles CARPENTIER, Axel TOLLANCE PhD, Antoine TURZI.
All you need to know. Another look ANGIOGENESIS, A KEY STEP IN TISSUE REGENERATION, IS MODULATED BY PLAQUES. Sarah BERNDT PhD1, Gilles CARPENTIER2, Axel TOLLANCE PhD1,3, Antoine TURZI1 1 Regen Lab SA, 1052 Le Mont-sur-Lausanne, Switzerland. 2 Gly-CRRET Research Unit 4397, Université Paris-Est Créteil, Créteil, France. 3 Department of Orthopedic Surgery, Geneva [...]
LM N°1/ 2024. Autologous PRP or "The Fairy Plate" in the magical land of regenerative autologous cellular medicine. Antoine TURZI. CEO of RegenLab
Platelet Rich Plasma (PRP) has emerged as an innovative therapeutic modality in a variety of medical fields, offering promising prospects for wound healing, facial rejuvenation and even genital rejuvenation.
Our clinical research is resolutely committed to studying these applications, seeking to determine the efficacy and safety of RegenPRP® (standardized PRP prepared with technology from RegenLab SA, Switzerland) in these varied clinical contexts.
LM N°1/ 2024. Look & Medicine interviews. The promises of "the Fairy platelet" for autologous regenerative cell therapy. The promises of "the Fairy platelet" for autologous regenerative cell therapy. Antoine TURZI, CEO of RegenLab. Interview by Pr Albert Claude BENHAMOU, Past President of the French National Academy of Surgery.
plaquetas sanguíneas". Las promesas del " Hada de las plaquetas " para la terapia celular regenerativa autóloga. plaquetas sanguíneas ". Las promesas del " Hada de las plaquetas " para la terapia celular regenerativa autóloga. plaquetas sanguíneas ". Las promesas del " Hada de las plaquetas " para la terapia celular regenerativa autóloga. plaquetas sanguíneas ". Las promesas del "Hada de las plaquetas" para [...].
LM N°1/ 2024. Look & Medicine interviews. The promises of "the Fairy platelet" for autologous regenerative cell therapy. The promises of "the Fairy platelet" for autologous regenerative cell therapy. Antoine TURZI, CEO of RegenLab. Interview with Pr Albert Claude BENHAMOU, Past President of the French National Academy of Surgery. Interviews with "L&M".
LES PROMESSES DE " LA FÉE PLAQUETTE " POUR LA MÉDÉCINE RÉGNÉRATIVE CELLULAIRE AUTOLOGUE THE PROMISES OF " THE PLATELET FAIRY " FOR AUTOLOGOUS REGENERATIVE CELL THERAPY. LAS PROMESAS " DEL HADA PLAQUETA " PARA LA TERAPIA CELULAR REGENERATIVA AUTOLOGA. Antoine TURZI, CEO of RegenLab